Official 2024 U.S. DOL Form 5500 summary for Ultragenyx Pharmaceutical INC. (Ultragenyx Pharmaceutical INC. 401(k) Plan And Trust · EIN 27-2546083 · PN 001): $217.92M net assets, 1,082 active participants, and $5.72 per $10,000 (5.72 bps).
| Plan Sponsor | Ultragenyx Pharmaceutical INC. |
|---|---|
| Filing Identifier | Ultragenyx Pharmaceutical INC. 401(k) Plan And Trust · EIN 27-2546083 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (CA) |
| Asset-Size Peer Cohort | $100M-$500M |
| Plan Net Assets (2024) | $217.92M |
| Active Participants | 1,082 |
| Direct Admin Fee Rate | $5.72 per $10,000 (5.72 bps) |
| Cohort Peer Median | $9.75 per $10,000 (9.75 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI
Verified federal filings reconciled for Ultragenyx Pharmaceutical across sibling Meru AI platforms.